Sign in

CIK 0001672619

  • Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811523849
Phone
+1 650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
  1. 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at $20.41 ($66,327)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale CHIEF OPERATING OFFICER sold 6,667 shares at $21.93 ($146,206)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,000 shares at $22.52 ($22,524)
  15. 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at $21.59 ($70,178)
  16. 4 Planned sale CHIEF OPERATING OFFICER sold 28,367 shares at an average $24.18 ($685,868)
  17. 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,000 shares at $25.04 ($25,039)
  18. 4 Planned sale CHIEF FINANCIAL OFFICER sold 4,250 shares at an average $22.23 ($94,474)
  19. 4 Planned sale CHIEF FINANCIAL OFFICER sold 5,250 shares at an average $24.89 ($130,688)
  20. 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,250 shares at an average $28.56 ($178,485)

Page 6 of 20 · 383 filings